Compounds > 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin
Page last updated: 2024-09-03

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Water-Electrolyte Imbalance

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Water-Electrolyte Imbalance in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arroyo, V; Asbert, M; Claria, J; Guarner, F; Jiménez, W; La Villa, G; López, C; Rivera, F; Rodés, J1

Other Studies

1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Water-Electrolyte Imbalance

ArticleYear
Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
    Gastroenterology, 1989, Volume: 97, Issue:5

    Topics: Animals; Arginine Vasopressin; Diuresis; Kidney; Liver Cirrhosis, Experimental; Male; Rats; Rats, Inbred Strains; Vasopressins; Water-Electrolyte Imbalance

1989